← Eichor
Study identifier: NCT06204549 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk

Condition: Adverse Cardiac Event · Major Adverse Cardiac Events  ·  Sponsor: University Hospital, Montpellier

PhaseNA
Planned participants70
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of assessing and managing cardiovascular risk is to avoid, limit or delay cardiovascular morbidity and mortality. Planned internal medicine hospitalization is developed around the management of cardiovascular risk in patients at high cardiovascular risk, whether in primary prevention or secondary prevention. During planned hospitalization, patients benefit from comprehensive, personalized and adapted care for their comorbidities and their CVRF (cardiovascular risk factors). This study will make it possible to evaluate this overall course of multidisciplinary management of comorbidities of patients at high cardiovascular risk.

This description comes directly from the study's public registry record.

Talk to the study team

Fanny CARDON  ·  0033 4 67 33 08 24  ·  fanny-cardon@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (1)

University HospitalMontpellier, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06204549